Literature DB >> 9671710

Human thioredoxin reductase from HeLa cells: selective alkylation of selenocysteine in the protein inhibits enzyme activity and reduction with NADPH influences affinity to heparin.

S N Gorlatov1, T C Stadtman.   

Abstract

Human thioredoxin reductase (TR) contains selenocysteine (Secys) in a redox center [cysteine (Cys)-497,Secys-498] near the C-terminus. The essential role of Secys in TR isolated from HeLa cells was demonstrated by the alkylation studies. Reaction of native NADPH reduced enzyme with bromoacetate at pH 6.5 inhibited enzyme activity 99%. Of the incorporated carboxymethyl (CM) group, 1.1 per subunit, >90% was in CM-Secys-498. Alkylation at pH 8 increased the stoichiometry to 1.6 per subunit with additional modification of the Cys-59, Cys-64 disulfide center. A minor tryptic peptide containing both CM-Cys-497 and CM-Secys-498 was isolated from enzyme alkylated at pH 6.5 or at pH 8. Preparations of TR isolated from HeLa cells grown in a fermentor under high aeration contained selenium-deficient enzyme species that had 50% lower activity. Decreasing oxygen to an optimal level increased cell yield, and fully active TR containing one Se per subunit was present. Reduction of fully active enzyme with tris-(2-carboxyethyl) phosphine converted it from a low to a high heparin affinity form. The tris-(2-carboxyethyl) phosphine-reduced enzyme was oxygen-sensitive and lost selenium and catalytic activity unless maintained under strictly anaerobic conditions. This enzyme could be converted to an oxygen-insensitive species by addition of NADPH, indicating that bound pyridine nucleotide is important for enzyme stability. An induced enzyme conformation in which the essential Secys is shielded from oxidative damage could explain these effects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671710      PMCID: PMC21108          DOI: 10.1073/pnas.95.15.8520

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Heparin-binding properties of selenium-containing thioredoxin reductase from HeLa cells and human lung adenocarcinoma cells.

Authors:  S Y Liu; T C Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 2.  Reduction of ribonucleotides.

Authors:  L Thelander; P Reichard
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

Review 3.  Thioredoxin.

Authors:  A Holmgren
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

4.  Inhibition of NF-kappaB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment.

Authors:  I Y Kim; T C Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Occurrence and characterization of selenocysteine in proteins.

Authors:  T C Stadtman
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

6.  Rapid analysis of amino acids using pre-column derivatization.

Authors:  B A Bidlingmeyer; S A Cohen; T L Tarvin
Journal:  J Chromatogr       Date:  1984-12-07

7.  Evidence for a functional relevance of the selenocysteine residue in mammalian thioredoxin reductase.

Authors:  L Marcocci; L Flohé; L Packer
Journal:  Biofactors       Date:  1997       Impact factor: 6.113

8.  Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue.

Authors:  L Zhong; E S Arnér; J Ljung; F Aslund; A Holmgren
Journal:  J Biol Chem       Date:  1998-04-10       Impact factor: 5.157

9.  Reduced thioredoxin: a possible physiological cofactor for vitamin K epoxide reductase. Further support for an active site disulfide.

Authors:  R B Silverman; D L Nandi
Journal:  Biochem Biophys Res Commun       Date:  1988-09-30       Impact factor: 3.575

10.  Evidence for the participation of Cys558 and Cys559 at the active site of mercuric reductase.

Authors:  S M Miller; M J Moore; V Massey; C H Williams; M D Distefano; D P Ballou; C T Walsh
Journal:  Biochemistry       Date:  1989-02-07       Impact factor: 3.162

View more
  15 in total

1.  Molecular modeling and in vitro activity of an HIV-1-encoded glutathione peroxidase.

Authors:  L Zhao; A G Cox; J A Ruzicka; A A Bhat; W Zhang; E W Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity.

Authors:  S R Lee; S Bar-Noy; J Kwon; R L Levine; T C Stadtman; S G Rhee
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  The efficiency of Escherichia coli selenocysteine insertion is influenced by the immediate downstream nucleotide.

Authors:  K E Sandman; C J Noren
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

Review 4.  Thioredoxin reductase.

Authors:  D Mustacich; G Powis
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

5.  Selectivity of labeled bromoethylamine for protein alkylation.

Authors:  Simona Marincean; Montserrat Rabago Smith; Laci Beltz; Babak Borhan
Journal:  J Mol Model       Date:  2012-05-29       Impact factor: 1.810

6.  Methaneseleninic acid is a substrate for truncated mammalian thioredoxin reductase: implications for the catalytic mechanism and redox signaling.

Authors:  Gregg Snider; Leah Grout; Erik L Ruggles; Robert J Hondal
Journal:  Biochemistry       Date:  2010-11-10       Impact factor: 3.162

7.  Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development.

Authors:  Cemile Jakupoglu; Gerhard K H Przemeck; Manuela Schneider; Stéphanie G Moreno; Nadja Mayr; Antonis K Hatzopoulos; Martin Hrabé de Angelis; Wolfgang Wurst; Georg W Bornkamm; Markus Brielmeier; Marcus Conrad
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

8.  Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence.

Authors:  L Zhong; E S Arnér; A Holmgren
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

9.  Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function.

Authors:  Marcus Conrad; Cemile Jakupoglu; Stéphanie G Moreno; Stefanie Lippl; Ana Banjac; Manuela Schneider; Heike Beck; Antonis K Hatzopoulos; Ursula Just; Fred Sinowatz; Wolfgang Schmahl; Kenneth R Chien; Wolfgang Wurst; Georg W Bornkamm; Markus Brielmeier
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

10.  Proteome changes in human bronchoalveolar cells following styrene exposure indicate involvement of oxidative stress in the molecular-response mechanism.

Authors:  Nora Mörbt; Iljana Mögel; Stefan Kalkhof; Ralph Feltens; Carmen Röder-Stolinski; Jiang Zheng; Carsten Vogt; Irina Lehmann; Martin von Bergen
Journal:  Proteomics       Date:  2009-11       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.